Recombinant Human TARDBP Protein，GST

TARDBP, or TAR DNA-binding protein, is a crucial protein involved in various cellular processes, including RNA metabolism, gene regulation, and neuroprotection. Its significance has gained prominence due to its link with neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Mutations in the TARDBP gene can lead to the formation of toxic aggregates in motor neurons, contributing to disease pathology. Research into TARDBP has focused on understanding its structure and function, as well as the impact of its pathological variants. The study of recombinant TARDBP proteins has become essential in elucidating the mechanisms by which these mutations disrupt normal cellular functions and lead to neurodegeneration. Moreover, the recombination technology enables scientists to produce purified TARDBP protein, facilitating biochemical assays, structural analysis, and investigations into interaction with RNA and other proteins. By studying TARDBP in vitro, researchers aim to uncover the molecular underpinnings of ALS and FTD, paving the way for potential therapeutic interventions targeting the misfolding and aggregation processes associated with these debilitating diseases. Overall, the investigation of recombinant TARDBP plays a pivotal role in advancing our understanding of its biology and the pathogenesis of related neurodegenerative disorders.